FRANKFURT— Bayer AG’s big push into the U.S. agrochemical market with its planned acquisition of Monsanto Co. could help it offset a growing problem on its home turf: increasingly stringent European regulation.
Merck & Co. said that an unknown number of people in up to 27 nations, including 60000 youngsters in Brazil, may need new shots to prevent infection with the hepatitis A virus because the vaccines
For the first time Merck & Co has unveiled how its closely watched experimental AIDS vaccine acts in humans, and several top scientists hailed the data as encouraging. In its presentation of
The pipeline for HIV drugs is getting fatter, adding several promising- through still early stage new compounds. Some of these experimental drugs, unveiled in Seattle at a large Conference on
Surgeons couldn't rid Sherri Putnam of a persistent liver tumor, but her doctor suggested that a high powered magnet and a liquid mixture containing microscopic metal beads might get the job done.
Elan Corp. said it halted permanently the development of a promising vaccine for Alzheimer's disease after several patients in a clinical trial of the medication became seriously ill. The future of
About 50 countries are expected to submit grant proposals this week to the new global fund to fight AIDS, malaria and tuberculosis, but fund officials acknowledge there probably isn't enough money to
Endocare Inc. a U.S. medical equipment supplier, launched plans to market in China a new surgical system designed to treat people infected with the hepatitis B virus, President Paul Mikus
Team of scientists as discovered how the deadly Ebola virus human cells, opening potential avenues to new drugs and a vaccine. Ebola kills about 80% of those who contract it, usually causing them to
Serno SA won its bid to sell its multiple-sclerosis drug Rebif in the U.S. after the Food and Drug Administration decided that patients will benefit more from the thrice-weekly dosage Serono drug
Merck & Co.'s announcement last week that it withdrew its application to sell Arcoxia, an arthritis drug similar to Vioxx, is another chapter in one of the most bitter and fascinating drug-marketing
